Showing results (191-200 of 231) with videos related to

Sort By:
Pageof 24
European Journal of Cancer (Oxford, England : 1990)|December 17, 2009
COX-2 expression in chondrosarcoma: a role for celecoxib treatment?Y M Schrage, I Machado, D Meijer, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 12, 2013
Bevacizumab plus preoperative chemotherapy in operable HER2 negative breast cancer: biomarkers and pathologic responseP Sánchez-Rovira, M A Seguí, A Llombart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 10, 2014
Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancerJ Baselga, A Manikhas, J Cortés, et al.
Breast Cancer Research and Treatment|May 19, 2015
Pegylated liposomal doxorubicin plus cyclophosphamide followed by paclitaxel as primary chemotherapy in elderly or cardiotoxicity-prone patients with high-risk breast cancer: results of the phase II CAPRICE studyMiguel J Gil-Gil, M Bellet, S Morales, et al.
British Journal of Cancer|April 29, 2010
Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancerJ Feliu, M J Safont, A Salud, et al.
The British Journal of Dermatology|January 22, 2008
Effect of proteasome inhibitors on proliferation and apoptosis of human cutaneous melanoma-derived cell linesA Sorolla, A Yeramian, X Dolcet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 11, 2012
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month resultsR Coleman, R de Boer, H Eidtmann, et al.
ESMO Open|March 9, 2024
Circulating tumor DNA for predicting recurrence in patients with operable breast cancer: a systematic review and meta-analysisG Nader-Marta, M Monteforte, E Agostinetto, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 28, 2007
Current controversies in the management of early breast cancerL G Estévez, M Martín, E Alba, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 7, 2019
Evolution of older patients diagnosed with early breast cancer in Spain between 1998 and 2001 included in El Alamo III projectMª D Torregrosa, M J Escudero, I Paredero, et al.
Pageof 24